Logo image of PRCT

PROCEPT BIOROBOTICS CORP (PRCT) Stock Overview

NASDAQ:PRCT - US74276L1052 - Common Stock

40.17 USD
-0.17 (-0.42%)
Last: 8/29/2025, 8:00:01 PM
40.17 USD
0 (0%)
After Hours: 8/29/2025, 8:00:01 PM

PRCT Key Statistics, Chart & Performance

Key Statistics
52 Week High103.81
52 Week Low37.12
Market Cap2.24B
Shares55.64M
Float53.23M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.55
PEN/A
Fwd PEN/A
Earnings (Next)10-27 2025-10-27/amc
IPO09-15 2021-09-15
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


PRCT short term performance overview.The bars show the price performance of PRCT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

PRCT long term performance overview.The bars show the price performance of PRCT in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40

The current stock price of PRCT is 40.17 USD. In the past month the price decreased by -19.6%. In the past year, price decreased by -49.15%.

PROCEPT BIOROBOTICS CORP / PRCT Daily stock chart

PRCT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.07 230.89B
ISRG INTUITIVE SURGICAL INC 58.79 169.67B
BSX BOSTON SCIENTIFIC CORP 37.28 156.32B
SYK STRYKER CORP 30.46 149.64B
MDT MEDTRONIC PLC 16.78 119.05B
BDX BECTON DICKINSON AND CO 13.52 55.31B
IDXX IDEXX LABORATORIES INC 53.88 51.77B
EW EDWARDS LIFESCIENCES CORP 31.65 47.75B
RMD RESMED INC 28.74 40.19B
GEHC GE HEALTHCARE TECHNOLOGY 15.82 33.66B
DXCM DEXCOM INC 44.32 29.55B
PHG KONINKLIJKE PHILIPS NVR- NY 16.42 26.56B

About PRCT

Company Profile

PRCT logo image PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. The company is headquartered in San Jose, California and currently employs 756 full-time employees. The company went IPO on 2021-09-15. The firm is focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The firm's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Company Info

PROCEPT BIOROBOTICS CORP

150 Baytech Drive

San Jose CALIFORNIA US

CEO: Reza Zadno

Employees: 756

PRCT Company Website

PRCT Investor Relations

Phone: 16502329832

PROCEPT BIOROBOTICS CORP / PRCT FAQ

What is the stock price of PROCEPT BIOROBOTICS CORP today?

The current stock price of PRCT is 40.17 USD. The price decreased by -0.42% in the last trading session.


What is the ticker symbol for PROCEPT BIOROBOTICS CORP stock?

The exchange symbol of PROCEPT BIOROBOTICS CORP is PRCT and it is listed on the Nasdaq exchange.


On which exchange is PRCT stock listed?

PRCT stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for PROCEPT BIOROBOTICS CORP stock?

19 analysts have analysed PRCT and the average price target is 68.44 USD. This implies a price increase of 70.38% is expected in the next year compared to the current price of 40.17. Check the PROCEPT BIOROBOTICS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is PROCEPT BIOROBOTICS CORP worth?

PROCEPT BIOROBOTICS CORP (PRCT) has a market capitalization of 2.24B USD. This makes PRCT a Mid Cap stock.


How many employees does PROCEPT BIOROBOTICS CORP have?

PROCEPT BIOROBOTICS CORP (PRCT) currently has 756 employees.


What are the support and resistance levels for PROCEPT BIOROBOTICS CORP (PRCT) stock?

PROCEPT BIOROBOTICS CORP (PRCT) has a support level at 38.81 and a resistance level at 41.12. Check the full technical report for a detailed analysis of PRCT support and resistance levels.


Is PROCEPT BIOROBOTICS CORP (PRCT) expected to grow?

The Revenue of PROCEPT BIOROBOTICS CORP (PRCT) is expected to grow by 46.4% in the next year. Check the estimates tab for more information on the PRCT EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy PROCEPT BIOROBOTICS CORP (PRCT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PROCEPT BIOROBOTICS CORP (PRCT) stock pay dividends?

PRCT does not pay a dividend.


When does PROCEPT BIOROBOTICS CORP (PRCT) report earnings?

PROCEPT BIOROBOTICS CORP (PRCT) will report earnings on 2025-10-27, after the market close.


What is the Price/Earnings (PE) ratio of PROCEPT BIOROBOTICS CORP (PRCT)?

PROCEPT BIOROBOTICS CORP (PRCT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.55).


What is the Short Interest ratio of PROCEPT BIOROBOTICS CORP (PRCT) stock?

The outstanding short interest for PROCEPT BIOROBOTICS CORP (PRCT) is 13.37% of its float. Check the ownership tab for more information on the PRCT short interest.


PRCT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PRCT Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to PRCT. While PRCT seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRCT Financial Highlights

Over the last trailing twelve months PRCT reported a non-GAAP Earnings per Share(EPS) of -1.55. The EPS increased by 24.76% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -16.4%
ROE -21.81%
Debt/Equity 0.13
Chartmill High Growth Momentum
EPS Q2Q%30%
Sales Q2Q%48.41%
EPS 1Y (TTM)24.76%
Revenue 1Y (TTM)55.71%

PRCT Forecast & Estimates

19 analysts have analysed PRCT and the average price target is 68.44 USD. This implies a price increase of 70.38% is expected in the next year compared to the current price of 40.17.

For the next year, analysts expect an EPS growth of 13.91% and a revenue growth 46.4% for PRCT


Analysts
Analysts82.11
Price Target68.44 (70.38%)
EPS Next Y13.91%
Revenue Next Year46.4%

PRCT Ownership

Ownership
Inst Owners93.86%
Ins Owners4.04%
Short Float %13.37%
Short Ratio6.43